Related Experiment Video
Updated: Jun 27, 2026
10:21
Protein Target Prediction and Validation of Small Molecule Compound
Published on: February 23, 2024
Prospects for China's Pharmaceutical Industry Development During the 15th Five-Year Plan Period
Hui-Li Cao1, Bo-Yang Li1, Guo-Xu Wei1
1Consumer Goods Industry Research Center, China Center for Information Industry Development, Beijing 100048, China.
Summary
China's pharmaceutical industry is at a critical juncture for high-quality development during the 15th Five-Year Plan. Strategic adjustments and emerging technologies present opportunities, requiring innovation and ecosystem optimization.
Area of Science:
- Pharmaceutical industry analysis
- Strategic sector assessment
- Innovation and competition dynamics
Background:
- The pharmaceutical sector is vital for national economy, development, and security.
- It's characterized by rapid scientific innovation, intense global competition, and significant policy focus.
- Profound global shifts and technological advancements necessitate strategic planning for China's pharmaceutical industry.
Purpose of the Study:
- To analyze the characteristics and strategic positioning of the pharmaceutical industry.
- To review global pharmaceutical industry trends and China's current status.
- To identify key factors for achieving high-quality development during the 15th Five-Year Plan period.
Main Methods:
- Systematic analysis of industry characteristics and strategic positioning.
- Review of global pharmaceutical development landscape and trends.
- Objective summary of China's pharmaceutical industry status (scale, innovation, clustering, internationalization).
Main Results:
- China's pharmaceutical industry faces five new situations: strategic positioning, market demands, emerging technologies, growth drivers, and an evolving landscape.
- Opportunities are assessed to outweigh challenges during the 15th Five-Year Plan.
- Key principles for high-quality development include scale expansion, innovation, business model adaptation, people-centered supply, and ecosystem optimization.
Conclusions:
- The 15th Five-Year Plan is crucial for China's pharmaceutical industry's high-quality growth.
- Strategic adherence to five core principles will drive industry advancement.
- Focus on innovation, market adaptation, and ecosystem enhancement is essential for future success.
Related Concept Videos
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:26FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...